WHO ICTRP trial

A retrospective study on the effects of Dexmedetomidine treatment on sleep…

ChiCTR2400081541 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting

Key facts

Trial ID ChiCTR2400081541
Public title A retrospective study on the effects of Dexmedetomidine treatment on sleep quality in patients with chronic moderate to severe insomnia.
Scientific title A retrospective study on the effects of Dexmedetomidine treatment on sleep quality in patients with chronic moderate to severe insomnia.
Primary sponsor The Second Affiliated Hospital of Air Force Medical University
Registry Chinese Clinical Trial Registry (ChiCTR)
Recruitment status Not Recruiting
Study type Observational study
Phase Retrospective study
Countries China
Conditions Chronic moderate to severe insomnia
Interventions Dexmedetomidine treatment group:Dexmedetomidine infusion starts at 22:00 each night, with a slow pump infusion at a dose of 0.5µg/kg over a duration of 15 minutes. Subsequently, the infusion is maintained at a rate of 0.1µg/kg/h. The…
Registration date Mar 4, 2024
Target size Dexmedetomidine treatment group:30;Conventional treatment group:150
Registry page chictr.org.cn

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations